Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Introducing The HG TRIAL Management of Pelvic Girdle Pain in Pregnancy using Harness Gravidarum A New Trial to test out a new Innovation! • In response to his wife’s pelvic pain in pregnancy, a man from Anglesey - Dafydd Roberts, designed and produced a harness specifically to tackle this common but sometimes debilitating problem. • Dafydd is hopeful this harness can improve the discomfort experienced by many women in pregnancy due to pelvic girdle pain. • The only way to find out how effective this harness may be is to do a clinical trial! • Dafydd teamed up with Consultant Obstetrician Kalpana Upadhyay to plan this trial. • Application for funding approved via Pathway to Portfolio pathway. Background • Nearly 20% of pregnant women experience pelvic girdle pain during pregnancy which can be back pain, pubic pain or pain in all the pelvic joints. • Of these women, 2.3% experience severe anterior or Symphysis Pubic pain. • Despite such high incidence, this is much under researched area in obstetrics with no high quality evidence to suggest the best treatment. • Current treatments include analgesics, physiotherapy, support belts and acupuncture. • No studies in literature involving a support device including all the joints of the pelvis. • The new device – ‘Harness Gravidarum’ is designed to ease all types of pelvic pain and even lower back discomfort. Current management of PGP in BCUHB • Variable at the three sites. • Community midwives, obstetricians and occasionally GPs see women who complain of PGP. • The treatments offered include physiotherapy, analgesics, acupuncture, lifestyle modification, and pelvic support belts or braces. • Different belts offered at different sites. (No belts in East) • The belts given may or may not be designed for use in pregnancy. Pt presents reporting Pregnancy related Pelvic, lower back or hip pain Pregnancy related PGP is a manageable condition Less than 12/40 1. Provide Leaflet 2. Advice re; Condition Reassurance Risk factors Pain relief Posture Work Weight 12-32/40 Greater than 32/40 Provide Leaflet and Advice as with Early phase. if No improvement with advice and high pain score (VAS 7+/10) and / or Refer to physio if clinically indicated if or Severely limited mobility and may require walking aid. Physio referral indicated if severely affected (Admission prevention) Onset in first 12/52 and not well managed. and / or Pre/previous pregnancy back, hip, SIJ problems. Refer to Physiotherapy to assess for elements of condition suitable for intervention Assessment and Management plan as indicated Unsatisfactory outcome Refer back Satisfactory outcome Discharge Provide Advice as with other phases Demonstration of Harness on Model Aim To study the effectiveness of a special flexible harness in women with Pelvic Girdle Pain associated with changes in the measurement of pain severity, physical activity and improvement in quality of life compared to the standard treatment for this condition. Design • A single blinded two arm, randomised (1:1) controlled trial across the maternity units in BCUHB. • Recruitment will be from the pregnant women who have been referred for physiotherapy by the community midwife or obstetrician. Inclusion/Exclusion criteria INCLUSION CRITERIA EXCLUSION CRITERIA 1. Pregnant women between 20 and 36 weeks of pregnancy 1. 2. Have experienced pelvic girdle pain for at least two previous week Women with known high risk pregnancy for example placenta praevia 2. A history of major systemic bone disease 3. History of significant back or pelvic injury in past 4. Women on long term steroid medication 3. Have been given general information and advice on pelvic girdle pain in pregnancy 4. Have tried analgesics and physiotherapy without significant relief of symptoms Methodology • A written informed consent will be obtained. • A set of baseline questionnaires will be completed: Pain intensity - visual analogue score (VAS), Pelvic Girdle Questionnaire (PGP), Modified Oswestry Disability Questionnaire (MODQ) Satisfaction with life scale (SWLS) • Participants will be randomised (web based randomisation) to the intervention (Harness Gravidarum) or to the control group (standard lumbar belts) • Weekly phone calls to the participants for the next four weeks to monitor progress. • A physical follow up visit with Physiotherapist after 4 weeks of intervention • Further follow up at 3 and 6 months post delivery. Sample Size • Initial pilot consisting of 60 women (20 at each site of BCUHB) to look at suitability of outcome measures and overall feasibility of trial. The final RCT sample size after data collection from the pilot. • Further grant to assess health economics and potential savings to the NHS by evaluating reduced rates of induction of labour and subsequent caesarean sections if effectiveness of harness is demonstrated. Data Collection & Management Data from CRF and Questionnaires will be recorded on SPSS spreadsheet for statistical analysis. Regular monitoring of data by Chief Investigator and co investigators. Independent NHS expert for oversight on data monitoring issues. Statistical Analysis SPSS dataset. Univariate and multivariate analyses will be done. Descriptive statistics and tests on measures for pain severity, pain duration, physical activity and quality of life. Comparison analysis will be done on ‘Intention to treat’ basis. Point estimates and 95% confidence intervals will be presented for all outcomes. Main Outcome Measures Primary outcome • Improvement in pain severity and physical activity as assessed by changes in the pain scores and disability index in each group. Secondary outcome • Overall improvement in quality of life as assessed by the SLWS scores. Use of adjuncts to treatment like analgesics would also be considered as secondary outcome. Adverse events during study • CE marked device. • Participants instructed to contact CI at any time after randomisation if any complications develop. • All Serious Adverse Events (SAE) or Serious Adverse Device Events (SADE) would be investigated in line with BCUHB R&D policy The Team • Dr (Mrs) Kalpana Upadhyay (Chief Investigator) • Mr Dafydd Roberts (Sponsor) • Mrs Jan Fereday Smith (Co Investigator) • Ms Lynne Grundy (Co Investigator) • Ms Rebecca Burns (Trial Facilitator) • Dr Zoe Hoare & Dr Mohammed Hussein (NWORTH) – Statisticians, University of Bangor • Ms. Lindsay Ashton, Valerie Fletcher, Sarah Watkins (Senior Physiotherapists) • Ms. Caroline M Jones, Annette Bolger & Stella Wright (Research Officers) • Dr David Parker (Independent Oversight) Acknowledgements • Ms Sarah Davies (Research Midwife, BCUHB) • Mr Julian Breeze (Portfolio Development Officer, Bangor University) • R&D department BCUHB